87 related articles for article (PubMed ID: 16102578)
21. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
22. Nonsense-mediated decay of human LDL receptor mRNA.
Holla ØL; Kulseth MA; Berge KE; Leren TP; Ranheim T
Scand J Clin Lab Invest; 2009; 69(3):409-17. PubMed ID: 19148831
[TBL] [Abstract][Full Text] [Related]
23. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
[TBL] [Abstract][Full Text] [Related]
24. NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.
Buffart TE; Tijssen M; El-Bchiri J; Duval A; van de Wiel MA; Ylstra B; Meijer GA; Carvalho B
BMC Med Genomics; 2009 Jun; 2():39. PubMed ID: 19563644
[TBL] [Abstract][Full Text] [Related]
25. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
26. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
[TBL] [Abstract][Full Text] [Related]
27. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
28. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.
Rochester MA; Riedemann J; Hellawell GO; Brewster SF; Macaulay VM
Cancer Gene Ther; 2005 Jan; 12(1):90-100. PubMed ID: 15499378
[TBL] [Abstract][Full Text] [Related]
29. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
Dasari VK; Deng D; Perinchery G; Yeh CC; Dahiya R
J Urol; 2002 Jan; 167(1):335-8. PubMed ID: 11743352
[TBL] [Abstract][Full Text] [Related]
31. Two nonsense mutations cause protein C deficiency by nonsense-mediated mRNA decay.
Luan CJ; Shen W; Yu Z; Chen L; Gu Y; Tang LY; Wang ZG; Dai L; Gu MM
Thromb Res; 2015 Apr; 135(4):733-8. PubMed ID: 25648792
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
34. Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets.
Rehwinkel J; Letunic I; Raes J; Bork P; Izaurralde E
RNA; 2005 Oct; 11(10):1530-44. PubMed ID: 16199763
[TBL] [Abstract][Full Text] [Related]
35. Nonsense-mediated mRNA decay (NMD) blockage promotes nonsense mRNA stabilization in protein 4.1R deficient cells carrying the 4.1R Coimbra variant of hereditary elliptocytosis.
Morinière M; Delhommeau F; Calender A; Ribeiro L; Delaunay J; Baklouti F
Blood Cells Mol Dis; 2010 Dec; 45(4):284-8. PubMed ID: 20863723
[TBL] [Abstract][Full Text] [Related]
36. An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer.
Mamo A; Cavallone L; Tuzmen S; Chabot C; Ferrario C; Hassan S; Edgren H; Kallioniemi O; Aleynikova O; Przybytkowski E; Malcolm K; Mousses S; Tonin PN; Basik M
Oncogene; 2012 Apr; 31(16):2090-100. PubMed ID: 21892209
[TBL] [Abstract][Full Text] [Related]
37. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
[TBL] [Abstract][Full Text] [Related]
38. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?
Anczuków O; Ware MD; Buisson M; Zetoune AB; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S
Hum Mutat; 2008 Jan; 29(1):65-73. PubMed ID: 17694537
[TBL] [Abstract][Full Text] [Related]
39. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
[TBL] [Abstract][Full Text] [Related]
40. Nonsense-mediated mRNA decay of collagen -emerging complexity in RNA surveillance mechanisms.
Fang Y; Bateman JF; Mercer JF; Lamandé SR
J Cell Sci; 2013 Jun; 126(Pt 12):2551-60. PubMed ID: 23729740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
